Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcus Biosciences (RCUS) Revenue (2017 - 2025)

Arcus Biosciences (RCUS) has 9 years of Revenue data on record, last reported at $15.0 million in Q4 2025.

  • For Q4 2025, Revenue changed N/A year-over-year to $15.0 million; the TTM value through Dec 2025 reached $203.0 million, changed N/A, while the annual FY2025 figure was $247.0 million, 6275.0% up from the prior year.
  • Revenue reached $15.0 million in Q4 2025 per RCUS's latest filing, down from $160.0 million in the prior quarter.
  • Across five years, Revenue topped out at $354.6 million in Q4 2021 and bottomed at -$73.0 million in Q3 2024.
  • Average Revenue over 5 years is $52.2 million, with a median of $28.0 million recorded in 2025.
  • Peak YoY movement for Revenue: surged 3456.84% in 2021, then plummeted 328.12% in 2024.
  • A 5-year view of Revenue shows it stood at $354.6 million in 2021, then tumbled by 90.51% to $33.7 million in 2022, then decreased by 7.89% to $31.0 million in 2023, then crashed by 335.48% to -$73.0 million in 2024, then soared by 120.55% to $15.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $15.0 million in Q4 2025, $160.0 million in Q2 2025, and $28.0 million in Q1 2025.